Genus Regulatory News (GNS)

FOR IMMEDIATE RELEASE

2 November 2017

Genus plc

Non-Executive Director Retirement

Genus plc (LSE: GNS), a leading global animal genetics company, announces that Duncan Maskell, Non-Executive Director, has informed the Company of his intention to step down from the Genus Board, effective from the 2018 Annual General Meeting. Professor Maskell has served as a Non-Executive Director and advisor to the Company's Research and Development Portfolio Management Team for almost four years and has announced his intention to move to Melbourne, Australia following his appointment as Vice-Chancellor of the University of Melbourne.

Commenting on Professor Maskell's departure, Bob Lawson, Chairman of Genus, said:

"I'm delighted that Duncan is able to continue his work as a Non-Executive Director over the course of the next year, while he settles into his new role at the University of Melbourne. Over the last four years, Duncan has provided the Company with significant scientific expertise, guidance and insight as we progress our innovative platforms in genomics, gene editing and biosystems engineering. We look forward to continuing to work with Duncan over the next year, and wish him the very best in his new role."

For further information please contact:

Genus:

Bob Lawson, Chairman Tel: +44 (0)1256 345970

Karim Bitar, Chief Executive

Buchanan:

Charles Ryland / Vicky Hayns Tel: +44 (0)207 466 5000